3BQQ

crystal structure of human saposin d (triclinic)

• Total interactions analyzed: 6
• Total true interactions: 5
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 47
  • Norm. En. per Res.: -3.2115
• Hub Node: C(3)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
C-A	-29.2896	8.3747	-102.279	-123.1939	45	3	1	3649	1	9	14
C-B	0.0	0.0	-0.0095	-0.0095	4	0	0	3	0	2	2
C-D	-19.5013	28.3149	-149.676	-140.8624	46	4	0	4881	0	10	16
A-B	-17.5114	7.8971	-141.326	-150.9403	47	4	0	5073	0	11	17
A-D	0.0	31.2966	-6.2551	25.0415	9	0	0	185	0	1	4

Interface residues

• C-A: ALA30C, ALA31C, ARG17A, ARG17C, ASN18A, ASN18C, ASP16A, ASP41A, ASP41C, ASP48C, CYS36A, CYS36C, GLN44A, GLN44C, GLU20A, GLU27C, GLU33C, GLY13A, GLY35A, GLY35C, LEU11A, LEU15A, LEU19A, LEU19C, LEU39A, LEU39C, LYS10A, LYS10C, LYS34A, LYS34C, LYS45C, LYS9A, PHE38A, PHE38C, PRO40A, PRO40C, PRO42A, PRO42C, SER37A, SER37C, TYR14A, TYR14C, TYR43A, TYR43C, VAL12A
• C-B: ASP41B, GLU27C, LYS34C, PRO42B
• C-D: ALA52C, ALA52D, ALA77C, ASP1C, ASP41C, ASP41D, ASP48C, ASP48D, CYS47C, CYS47D, CYS5C, CYS5D, GLN44C, GLN44D, GLN46C, GLN46D, GLN49C, GLN49D, GLU53C, GLU53D, GLU6C, GLU6D, GLY2C, GLY2D, GLY3C, GLY3D, LEU39C, LEU39D, LYS10C, LYS10D, LYS45C, LYS45D, PHE4C, PHE4D, PHE50C, PHE50D, PRO40C, PRO40D, PRO42C, PRO42D, TYR43C, TYR43D, TYR54C, TYR54D, VAL7C, VAL7D
• A-B: ALA52A, ALA52B, ALA77A, ALA77B, ASP1A, ASP41A, ASP41B, ASP48A, ASP48B, CYS47A, CYS47B, CYS5A, CYS5B, GLN44A, GLN44B, GLN46A, GLN46B, GLN49A, GLN49B, GLU53A, GLU53B, GLU6A, GLU6B, GLY2A, GLY2B, GLY3A, GLY3B, LEU39A, LEU39B, LYS10A, LYS10B, LYS45A, LYS45B, PHE4A, PHE4B, PHE50A, PHE50B, PRO40A, PRO40B, PRO42A, PRO42B, TYR43A, TYR43B, TYR54A, TYR54B, VAL7A, VAL7B
• A-D: ARG17A, ASN18A, ASN22A, ASP41D, GLN44D, GLU20A, LEU19A, PRO40D, PRO42D